A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation

A. Shoemark (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), L. Carreto (Amadora, Portugal), A. Smith (Dundee, United Kingdom), M. Oriano (Milan, Italy), H. Keir (Dundee, United Kingdom), L. Perea (Barcelona, Spain), E. Canto (Barcelona, Spain), L. Terranova (Milan, Italy), S. Vidal (Barcelona, Spain), K. Moffitt (Belfast, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom)

Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Session: Advances in bronchiectasis and non-TB mycobacterial infections
Session type: Oral Presentation
Number: 4947
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Shoemark (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), L. Carreto (Amadora, Portugal), A. Smith (Dundee, United Kingdom), M. Oriano (Milan, Italy), H. Keir (Dundee, United Kingdom), L. Perea (Barcelona, Spain), E. Canto (Barcelona, Spain), L. Terranova (Milan, Italy), S. Vidal (Barcelona, Spain), K. Moffitt (Belfast, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom). A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation. 4947

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019



COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013


Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006


Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


A?-Val360: a marker of neutrophil elastase and COPD disease activity
Source: Eur Respir J 2013; 41: 31-38
Year: 2013



Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum
Source: Eur Respir J 2002; 20: Suppl. 38, 143s
Year: 2002

Bacterial infection, IL-8 and elastase activity in children with chronic bronchiolitis and bronchial asthma in stable period
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003

Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003



Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD.
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017


Can neutrophil to lymphocyte ratio be used as infection marker in COPD patients with chronic respiratory failure
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016


Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Airway neutrophilia in COPD is not associated with increased neutrophil survival
Source: Eur Respir J 2006; 28: 1163-1169
Year: 2006



Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003



Neutrophil elastase in severe COPD and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006

COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003



Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020